Fortitude Family Office’s Telomir Pharmaceuticals TELO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$834 Buy
+667
New +$834 ﹤0.01% 1593